BBC: Nvidia has firmly ruled out letting ousted co-founder Jensen Huang return as it revealed that sales doubled to more than $100bn. In the company's first results since Huang's dramatic exit last week, interim chief executive Colette Kress said it is "business as usual" and told investors: "We've got this." Earlier on Tuesday, Huang said he would be "honoured" to return and lead Nvidia, having quit following alleged extramarital affairs, including one with a suspected spy for China. But Nvidia's chair Harvey Jones said "The board does not intend to reinstate him."

Comment: There are three circumstances when a board that has not founded a company would want to sack a founding CEO: when it is doing very well, or very badly, or just anyway. Huang joins a list including Elon Musk and Steve Jobs of brilliant people kicked out by the mediocre. It is also evident that the alleged extramarital affairs, or spying may not have done any harm to the company, if the latest sales surge is anything to go by.

Alliance News: UK consumer price inflation accelerates to 3.6% annually in October from 3.5% in September, but remains below the FXStreet-cited consensus forecast of 3.7%, according to figures from the Office for National Statistics. On a monthly basis, consumer prices rise 0.5%, accelerating from 0.4% in September and matching expectations. Annual core inflation, which excludes energy, food, alcohol and tobacco, remains unchanged at 2.8%, in line with forecasts. The ONS says transport, particularly motor fuels, makes the largest upward contribution to annual inflation, while restaurants and hotels provide the largest downward contribution. Meanwhile, the consumer prices index including owner occupiers' housing costs rises 3.7% annually, up from 3.6%.

Comment: It is perhaps a shame that the cost of fuel is over half tax. Or that despite the breadcrumbs of Burnham insisting on his pathetically small everyday fixes make a difference against stratospheric income and council tax, we actually have inflation anywhere under 10%. It is still the case that it is a cost of taxation crisis, rather than a cost of living one, and taxation is a government choice.

Sulnox (AQSE:SNOX),  the greentech company delivering lower fuel costs and emissions with zero capex, announced that it has been granted a strategically important patent in Canada, completing patent coverage across North America’s three largest economies. The company obtained its US patent in June 2023, followed by a Mexican patent in August 2025. Consistent with Sulnox's extensive portfolio of more than 100 patents granted in major markets worldwide, the latest patent covers a range of emulsification formulations for heavy fuel oils and Sulnox Eco™ Fuel Conditioners, which enhance diesel, petrol/gasoline and biofuels, as well as marine fuels including Marine Gas Oil (MGO), Marine Diesel Oil (MDO), Very and Ultra Low Sulphur Fuel Oils (VLSFO/ULSFO) and High Sulphur Fuel Oil (HSFO).

Comment: It has almost become a cliché that most people are in the habit of dismissing Aquis, but that there is a company or two on the challenger exchange which is decent. While we may be recovering from the proposed exit of IntelliAM (INT), the £45m market cap SNOX looks like a bona fide blue chip in the making, and in an à la mode sector. 

B HODL Plc (AQSE: HODL),  the first British company founded to Buy, Hold, Deploy and Compound Bitcoin, is pleased to announce the purchase of Bitcoin as part of its ongoing treasury strategy “Mission: Compound Bitcoin”. The Company remains focused on the disciplined acquisition of Bitcoin to build a long-term strategic reserve that also powers B HODL’s Bitcoin Deployment operations. This purchase was funded by a loan from OKX, secured against a portion of the Company’s existing Bitcoin holdings. The Board will continue to manage the facility within its treasury strategy, with the objective of increasing Bitcoin per share over time. Details of the purchase are as follows:

●       Number of Bitcoin acquired: 1 BTC

●       Average purchase price: £49,497 per Bitcoin (US$65,296 per Bitcoin)

Comment: One has almost assumed with BTC tanking yet again, there would not be any companies who feel that continuing with last year’s Treasury model is a strategy worth continuing. This is unless buying BTC at half last year’s peak at $126k is going to be seen as the smartest thing to do in the crypto space in future. Oh yes,  just the 1 BTC?

Fulcrum Metals plc (FMET),  which is developing a scalable platform to recover precious and critical metals from mine waste using Extrakt Process Solutions’ cyanide-free technology, notes the announcement released by Terra Balcanica Resources Corp. on 17 November 2026, that its spin-out, Terra North Resources Corp., has reported encouraging exploration results at the Charlot-Neely Lake uranium project in Saskatchewan, Canada. Charlot-Neely forms part of Fulcrum’s Saskatchewan uranium portfolio, over which Terra North holds an option to acquire a 100% interest. Fulcrum retains exposure through its equity holdings in Terra North and Terra, further potential consideration under the option agreement and a 1% net smelter return royalty upon exercise of the option.

Comment: We have already seen over the past year how FMET has become a grown up company (scalable), helped along by its technology and the boom in critical metals. Today’s news reminds us that the company has certainly come of age, especially with only a starter-level market cap of £10m.

OptiBiotix Health plc (OPTI) , a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes announces that its wholly owned subsidiary, OptiBiotix Limited, has entered into an exclusive distribution agreement (the “Agreement”) with CK Ingredients Inc. (“CK”) for its appetite-reducing SlimBiome ingredient in North America (Canada and the USA). OPTI said,  “We are very pleased to have signed a distribution agreement with CK Ingredients for our award-winning SlimBiome ingredient in the USA and Canada. CK are unique in the industry in that rather than supply a large portfolio of generic ingredients they focus on high value science-based ingredients like SlimBiome which require a more scientific and technical team. We look forward to building our business in the USA with CK.”

Comment: Alas, the history of OPTI has been so blighted by crackpot commentary / bullying that it is difficult to see the company for what it is, or the progress that is being made. Of course, this is probably the intention. Nevertheless, if one can see past all the spurious shenanigans, this may be a company actually worth looking at. It is also a blight on the London market that such shenanigans take place.

Landore Resources Limited (LND ) provided an update on its programme to evaluate and advance its portfolio of eight non-core properties in Nevada, USA. As part of this programme, a small number of surface samples have been assayed from four properties: HiHo, Charley, Spruce Mountain and Cimarron. Despite very limited accessible outcrop across the areas sampled, the programme returned encouraging precious and base-metal results, including 2,300 g/t silver, 6.86% copper, 7.60% lead and 26.8% zinc at Spruce Mountain, and gold values of up to 2.13 g/t at Cimarron. The results represent an encouraging first step in Landore’s strategy to re-evaluate a portfolio which has seen little recent exploration activity. The Company is also digitising and integrating the extensive historical geological and exploration information available for the Nevada properties to identify and prioritise opportunities for further work.

Comment: It would appear that LND is so chuffed with its progress, as well as the latest results that, apart from announcing them in an RNS, it feels it does not need to do anything else. Given that today’s 10% rebound has just taken the shares off year lows, it may want to re-think its PR strategy / have one, the “investor hub” notwithstanding.

Neo Energy Metals plc (NEO)  provides an update on the regulatory process relating to its proposed acquisition of the Beatrix 4 Shaft from Sibanye-Stillwater Limited and the Company’s funding strategy. Highlights: Confirmation of status of the New Beisa (Beatrix 4) regulatory process to assume ownership. Neo Energy is pursuing a phased financing approach, focused on cash preservation and identifying an anchor investor ahead of the requisite regulatory consents.

New Beisa Regulatory Process

Regulatory timing and decisions remain subject to the DMPR. Neo will continue to mitigate the impact of delays where reasonably possible and update shareholders on material developments.

Comment: Everything may be tickety boo as far as the fundamentals of the proposed acquisition that NEO is making. However, the share price is sinking like a stone and therefore shareholders will need to be treated to very pleasant and speedy updates on progress.

Potentially AI PLC (AGI),  the collective AI company, announced the launch of a closed beta for its workspace, alongside the appointment of Rodolfo Fanti as Creative and Innovation Director.

Workspace closed beta

The Company's beta demo app has been installed more than 100,000 times. From this community, a small sample will be invited into the closed beta of the Company's new web workspace. A central aim of the programme is to understand the use cases that matter most to users, informing the enhanced platform and the marketplace to follow. The Company also welcomes other interested users to register at potentially.com to be among the earliest testers of the workspace.

Appointment of Creative and Innovation Director

The Company has appointed Rodolfo Fanti as Creative and Innovation Director, joining on 1 December 2026. Rodolfo leads creative technology and generative AI innovation for Hollywood studios.

Comment: Although perhaps something of a niche area, getting 100,000 people to click on anything other than something non-wholesome, has to be regarded as something of an achievement. This is in addition to the notional 9x improvement for the AGI share price so far this year.

TheraCryf (TCF),  the biotech company developing new medicines for addiction and other neuropsychiatric disorders such as fatigue, announces that it has submitted an application to the Bellberry Human Research Ethics Committee ("HREC") in Australia for a first-in-human Phase 1 study of its lead orexin-1 (Ox-1) receptor antagonist. The application was submitted on behalf of the Company’s wholly owned subsidiary, TheraCryf Australia Pty Ltd, in line with the November 2026 timetable previously announced. The submission follows completion of the preclinical data package announced on 19 October 2026, including the final reporting of the 28-day regulatory toxicology studies in two species. Following anticipated HREC approval, the Company will lodge a Clinical Trial Notification (CTN) with Australia’s Therapeutic Goods Administration (TGA). The Company continues to target the necessary approvals by the turn of this calendar year. Australia provides an efficient and well-established pathway for early-stage clinical studies, which was a key factor in the Company's decision to conduct its Phase 1 programme there.

Comment: Although perhaps only five people in this country, or any country will be familiar with the delights of an Ox-1 receptor antagonist, it is clear that TCF is doing good work, if not God’s work. That said, we are heading for the shares to be down four years in a row, and today’s news regards only Phase 1, so there is a way to go here to get to the Promised Land.